Archive

  • M&G Catalyst impact strategy invests in vaccine developer

    18 March 2021

    M&G was lead investor in a funding round worth $168 million in Vaccitech, which co-invented a Covid-19 vaccine with the University of Oxford.

  • Liontrust identifies healthcare companies profiting from coronavirus response

    14 April 2020

    Liontrust Asset Management has identified some of the healthcare companies that can play a part in responding to the Covid-19 outbreak, while acknowledging the "morally difficult" implications of profiting from the pandemic.

Cookies on Environmental Finance

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more here